Proliferative Response of Pre–G-CSF and Post–G-CSF PBMNCs to Alloantigen Stimulation
Donor . | Cells . | 3H-Uptake (cpm) . | |
---|---|---|---|
. | . | Pre–G-CSF . | Post–G-CSF . |
A | MNC* | 4,968 (633) | 265 (14) |
B | MNC* | 4,419 (328) | 205 (53) |
C | MNC* | 2,212 (328) | 2,668 (197) |
D | MNC† | 6,648 (1,845) | 8,287 (934) |
E | MNC† | 10,324 (506) | 706 (78) |
F | MNC† | 13,157 (3,064) | 866 (193) |
CD4+‡ | 8,611 (1,936) | 9,957 (52) | |
CD8+ρ | 894 (246) | 1,382 (181) |
Donor . | Cells . | 3H-Uptake (cpm) . | |
---|---|---|---|
. | . | Pre–G-CSF . | Post–G-CSF . |
A | MNC* | 4,968 (633) | 265 (14) |
B | MNC* | 4,419 (328) | 205 (53) |
C | MNC* | 2,212 (328) | 2,668 (197) |
D | MNC† | 6,648 (1,845) | 8,287 (934) |
E | MNC† | 10,324 (506) | 706 (78) |
F | MNC† | 13,157 (3,064) | 866 (193) |
CD4+‡ | 8,611 (1,936) | 9,957 (52) | |
CD8+ρ | 894 (246) | 1,382 (181) |